HealthDay News — A program that integrates clinical pharmacists into established primary care medical home practices helps patients achieve better disease management for high blood pressure (HBP) and diabetes mellitus (DM), compared to usual care, according to a study published in the Journal of International Medical Research.
Kimberly D. Brunisholz, PhD, from Intermountain Healthcare in Salt Lake City, and colleagues retrospectively examined the effectiveness of the Intermountain Healthcare Collaborative Pharmacist Support Services (CPSS) program (2012 to 2015) among 359 adult patients diagnosed with DM and/or HBP. Patients were propensity-matched to a reference cohort of 999 participants.
The researchers found that, compared with the reference group, CPSS patients were 93% more likely to achieve a blood pressure goal <140/90 mm Hg, 57% more likely to achieve hemoglobin A1c values <8%, and 87% more likely to achieve both disease management goals.
Across the entire study period, time-to-goal achievement showed increased separation between the study cohorts (P < .001), particularly at 180 days post-intervention (HBP: P < .001; DM: P < .05).
“CPSS participation is associated with significant improvement in achievement of disease management goals, time to achievement, and increased ambulatory encounters compared with the matched no-CPSS cohort,” the authors write.
Brunisholz KD, Olson J, Anderson JW, et al. “Pharming out” support: a promising approach to integrating clinical pharmacists into established primary care medical home practices [published online January 1, 2017]. J Int Med Res. doi: 10.1177/0300060517710885.